本卡组中的卡片 (327)

正在搜索...
  • 1

    The clinical scenario involves a 6-year-old girl with a history of delayed motor and language development who experiences episodes of "staring off" lasting 2 minutes. After the episodes, she feels confused and wants to sleep.

    neurology pediatrics step2
  • 2

    For a child presenting with episodes of staring, turning the head to the left, and extending her left arm, one should consider the diagnosis of focal seizures.

    neurology pediatrics step2
  • 3

    In the examination of the girl, it was noted that there are a few hypopigmented macules covering her abdomen and lower extremities, which may suggest {{$c2::tuberous sclerosis}}.

    neurology step2
  • 4

    A child with a suspicion of tuberous sclerosis exhibiting episodes of staring and arm extension should undergo a brain imaging study such as an MRI to evaluate for cortical abnormalities.

    neurology step2
  • 5

    The standard first step in evaluating a child with unexplained neurological episodes, including staring spells, is to obtain an MRI of the brain which may reveal structural lesions.

    neurology step2
  • 6

    The condition characterized by benign tumors called hamartomas in various organ systems, particularly the CNS, is known as Tuberous sclerosis complex (TSC).

    neurology step2 tuberous_sclerosis
  • 7

    Key cutaneous findings in Tuberous sclerosis include hypopigmented macules, ash leaf spots, and angiofibromas.

    neurology step2 tuberous_sclerosis
  • 8

    In Tuberous sclerosis, the most common initial presentation is seizure.

    neurology step2 tuberous_sclerosis
  • 9

    Cognitive dysfunction occurs in nearly two thirds of patients with Tuberous sclerosis.

    neurology step2 tuberous_sclerosis
  • 10

    Tumors in Tuberous sclerosis may include cardiac rhabdomyomas and renal angiomyolipomas.

    neurology step2 tuberous_sclerosis
  • 11

    The genetic mutations causing Tuberous sclerosis are in either the TSC1 or TSC2 genes.

    neurology step2 tuberous_sclerosis
  • 12

    The clinical decision about managing a patient with suspected Tuberous sclerosis involves assessing for CNS lesions such as glioneuronal hamartomas and subependymal nodules.

    neurology step2 tuberous_sclerosis
  • 13

    Given a patient with a history of delayed development and episodes of 'staring off,' consider the diagnosis of Tuberous sclerosis.

    neurology step2 tuberous_sclerosis
  • 14

    The presence of hypopigmented macules or 'confetti' macules is often among the first cutaneous manifestations of Tuberous sclerosis in childhood.

    neurology step2 tuberous_sclerosis
  • 15

    True or False: Patients with Tuberous sclerosis are at risk for developing malignancies in soft tissues, brain, or kidney despite having benign tumors.

    neurology step2 tuberous_sclerosis
  • 16

    An MRI showing characteristic lesions is crucial in diagnosing Tuberous sclerosis.

    neurology step2 tuberous_sclerosis
  • 17

    For a clinical question related to Tuberous sclerosis, the critical factor to examine is the patient's history of seizures and other neurological symptoms.

    neurology step2 tuberous_sclerosis
  • 18

    The educational objective about Tuberous Sclerosis Complex (TSC) is that it is an autosomal dominant neurocutaneous disorder characterized by benign tumors called hamartomas.

    neurology step2
  • 19

    A common initial presentation of Tuberous Sclerosis Complex includes seizures.

    neurology step2
  • 20

    Distinctive cutaneous findings of TSC include hypopigmented macules, ash leaf spots, angiofibromas, a shagreen patch, and fibrous forehead plaque.

    neurology step2
  • 21

    In TSC, cognitive dysfunction is common, affecting nearly two thirds of patients.

    neurology step2
  • 22

    Cardiac tumors in Tuberous Sclerosis Complex include cardiac rhabdomyomas which can lead to mitral regurgitation.

    neurology step2
  • 23

    Renal tumors associated with TSC include angiomyolipomas which are benign but increase the risk for malignancies.

    neurology step2
  • 24

    A diagnosis of Linear Sebaceous Nevus is characterized by localized overgrowth of sebaceous glands, which is often not associated with seizures or development delay.

    neurology step2
  • 25

    Neurofibromatosis presents with cutaneous neurofibromas, café au lait spots, and pigmented iris hamartomas.

    neurology step2
  • 26

    Sturge-Weber Syndrome is characterized by nevus flammeus, which is also known as port-wine stain.

    neurology step2
  • 27

    Von Hippel-Lindau syndrome is associated with hemangioblastomas of the retina and CNS.

    neurology step2
  • 28

    The study design assessing cervical cerclage for preventing preterm birth is best described as a prospective cohort study. This type identifies a group with or without an exposure and evaluates outcomes based on that exposure.

    obgyn study_designs step2
  • 29

    In a prospective cohort study, the hypothesis and analysis protocols are established prior to the study period, unlike in a retrospective design where the protocol is created after the study period.

    obgyn study_designs step2
  • 30

    Cohort studies calculate relative risk (RR) by comparing outcomes between exposed and non-exposed groups, while case-control studies use the odds ratio (OR).

    obgyn study_designs step2
  • 31

    Descriptive studies are used to analyze trends and identify areas for research; they include case reports, case series, and cross-sectional studies.

    obgyn study_designs step2
  • 32

    If cervical length is found to be less than 25 mm, pregnant patients may be offered cerclage or bed rest as preventative measures against preterm birth.

    obgyn clinical_decision step2
  • 33

    A cohort study is characterized by following patients over time to investigate the impact of exposures or risk factors on an outcome of interest. The study design is identified as prospective cohort study when hypothesis and analysis are established prior to the start of the study period.

    medicine study_design step2
  • 34

    In a cohort study, relative risk (RR) is calculated by comparing the frequency of outcome in the exposed group to the non-exposed group.

    medicine epidemiology step2
  • 35

    Case-control studies compare patients based on disease outcome status and utilize the odds ratio (OR) to analyze exposure odds. They categorize patients into groups: cases with the disease and controls without it.

    medicine study_design step2
  • 36

    Descriptive studies are useful for describing new diseases, analyzing trends, and identifying areas for more rigorous research. These categories include case reports and cross-sectional studies.

    medicine study_design step2
  • 37

    Randomized studies are a stringent type of prospective study where patients are assigned to receive an intervention, often compared against placebo or a standard therapy. This design is considered the gold standard in medical research.

    medicine study_design step2
  • 38

    In prospective cohort studies, the intervention's effect is assessed after participants are randomized to either receive the intervention or a placebo. This design helps establish strong evidence compared to observational studies.

    medicine research step2
  • 39

    When analyzing the statistical measures associated with case-control studies, which measure should clinicians expect to use? The odds ratio (OR) is the appropriate statistical measure.

    medicine statistics step2
  • 40

    In postmenopausal women, a palpable ovary or pelvic mass raises concern for ovarian cancer. This is often indicated by an elevated CA-125 level.

    obgyn step2
  • 41

    The best next step in management for a postmenopausal woman with a palpable pelvic mass and elevated CA-125 is chemotherapy.

    obgyn step2
  • 42

    Common presenting features of ovarian cancer include weight loss, abdominal discomfort, and gastrointestinal symptoms.

    obgyn step2
  • 43

    When considering management for ovarian cancer, be aware that early detection can change outcomes, but many cases present late.

    obgyn step2
  • 44

    Important clinical decisions in managing ovarian cancer revolve around its metastatic potential and the significance of CA-125 tests.

    obgyn step2
  • 45

    {A relevant question about ovarian cancer management is illustrated as follows: What to do for a postmenopausal woman with masses and elevated CA-125?} Here is a reminder! The correct answer is presented as an image: image description

    obgyn step2
  • 46

    In a postmenopausal woman with a palpable ovary and elevated CA-125 concentration, the most appropriate next step is chemotherapy. What is the significance of this finding in relation to ovarian cancer?

    obgyn step2
  • 47

    A mass on pelvic examination in a postmenopausal woman may indicate ovarian cancer. What are some common symptoms associated with this diagnosis?

    obgyn step2
  • 48

    Ovarian cancer typically presents late in its course and is often metastatic. What are the common risk factors associated with developing this disease?

    obgyn step2
  • 49

    Major risk factors for ovarian cancer include BRCA1/2 mutations and Lynch syndrome. What other factors may contribute?

    obgyn step2
  • 50

    First-line treatment for initial ovarian cancer involves surgical resection followed by systemic chemotherapy. Why is early diagnosis critical?

    obgyn step2
  • 51

    In managing ovarian cancer, observation only is not appropriate. Which treatment option can be utilized for recurrent ovarian cancer?

    obgyn step2
  • 52

    The first-line treatment for initial ovarian cancer is platinum-based chemotherapy. What is a second-line option for platinum-resistant cases?

    obgyn step2
  • 53

    Radiation therapy is rarely utilized as a treatment for ovarian cancer due to its lower effectiveness compared to surgical resection and chemotherapy. What is the preferred initial approach?

    obgyn step2
  • 54

    What are presenting features of ovarian cancer? Common symptoms include weight loss, abdominal discomfort, and nausea.

    obgyn step2
  • 55

    Symptoms of bowel obstruction in ovarian cancer can result from locally invasive disease. What is peritoneal carcinomatosis?

    obgyn step2
  • 56

    In postmenopausal women, a palpable ovary raises concern for ovarian malignancy. The presence of an increased CA-125 concentration supports this diagnosis.

    obgyn step2
  • 57

    Ovarian cancer often presents with vague symptoms such as weight loss, abdominal discomfort, and ascites. It is usually discovered at an advanced stage.

    obgyn step2
  • 58

    Surgical resection followed by systemic chemotherapy is the first-line therapy for ovarian cancer.

    obgyn step2
  • 59

    Major risk factors for ovarian cancer include increased age, smoking, nulliparity, and polycystic ovarian syndrome.

    obgyn step2
  • 60

    Immunotherapy with bevacizumab can be a second-line option for treatment-resistant ovarian cancer when combined with chemotherapy.

    obgyn step2
  • 61

    Radiation therapy is rarely utilized for ovarian cancer due to its lower effectiveness compared to surgical resection and chemotherapy.

    obgyn step2
  • 62

    Increased frequency of ovarian cancer cases is observed in women with mutations in BRCA1/2 and Lynch syndrome.

    obgyn step2
  • 63

    The presence of bowel obstruction in ovarian cancer may indicate locally invasive disease or peritoneal carcinomatosis.

    obgyn step2
  • 64

    The educational objective highlights the need for early diagnosis, emphasizing that a palpable ovary in a postmenopausal woman raises concern for ovarian malignancy.

    obgyn step2
  • 65

    Common presenting symptoms of ovarian cancer include nausea, bloating, and early satiety.

    obgyn step2
  • 66

    Presentation of ovarian cancer is often nonspecific and can include symptoms like cramping and bowel obstruction.

    obgyn step2
  • 67

    In managing a patient with a history of intermittent milky discharge and elevated serum calcium, the presence of family history of pituitary tumors is indicative of a possible pituitary adenoma. What is the best next step in management after bromocriptine therapy?

    endocrinology pituitary step2
  • 68

    Elevated serum calcium levels (e.g., 12.4 mg/dL) in a patient with pituitary adenoma suggest the need to evaluate for a possible primary hyperparathyroidism.

    endocrinology calcium step2
  • 69

    In patients with family history of pituitary tumors, one should consider screening for potential genetic syndromes or imaging to assess for pituitary adenomas.

    endocrinology genetics step2
  • 70

    The management approach for a prolactinoma typically begins with dopaminergic agonists like bromocriptine, but may require surgical intervention if the patient is resistant to medical therapy.

    endocrinology prolactinoma step2
  • 71

    Signs of hyperprolactinemia include symptoms such as milky discharge from the breast and potentially menstrual irregularities.

    endocrinology hormones step2
  • 72

    For the management of hyperparathyroidism with concurrent hypercalcemia in the presence of a pituitary adenoma, resection might be required.

    endocrinology surgery step2
  • 73

    When evaluating a patient with elevated calcium and hyperparathyroidism, consider conditions like primary hyperparathyroidism or MEN syndrome.

    endocrinology hyperparathyroidism step2
  • 74

    The therapeutic goal for patients with elevated prolactin levels is often achieved through bromocriptine therapy, to normalize hormonal levels.

    medication hormones step2
  • 75

    If a female patient shows signs of galactorrhea and a significant family history of pituitary tumors, consider the likelihood of a hormonal imbalance or neoplasm.

    endocrinology diagnosis step2
  • 76

    In patients with irregular menses, the presence of elevated prolactin levels may warrant further investigation for underlying causes.

    gynecology hormones step2
  • 77

    In the context of managing hyperparathyroidism associated with MEN1 syndrome, the best next step is to perform subtotal parathyroid resection to reduce PTH secretion.

    surgery step2
  • 78

    Multiple endocrine neoplasia (MEN) syndromes are classified as autosomal dominant hereditary disorders that predispose individuals to tumors of the endocrine system.

    medicine step2
  • 79

    In MEN1, patients may develop primary hyperparathyroidism which is characterized by elevated levels of parathyroid hormone (PTH) and hypercalcemia.

    medicine step2
  • 80

    A patient with significant hypercalcemia and increased intact PTH levels is likely to benefit from counseling on surgical intervention for parathyroid resection.

    medicine step2
  • 81

    Management of symptomatic or marked hypercalcemia in patients with MEN1 typically involves surgical resection of involved glands.

    surgery step2
  • 82

    In cases of MEN1, pituitary tumors may secrete prolactin, leading to symptoms such as galactorrhea.

    neurology step2
  • 83

    Multiple endocrine neoplasia syndrome type 1 is characterized by pituitary, pancreatic, and parathyroid tumors.

    medicine endocrinology step2
  • 84

    Pituitary tumors may secrete prolactin leading to galactorrhea.

    medicine endocrinology step2
  • 85

    Common complications of parathyroid tumors in MEN1 include hyperparathyroidism and hypercalcemia.

    medicine endocrinology step2
  • 86

    For patients with MEN1 experiencing symptomatic or marked hypercalcemia, surgical resection is recommended to reduce PTH secretion.

    medicine surgery step2
  • 87

    The use of bromocriptine is beneficial to suppress pituitary secretion of prolactin in patients with pituitary tumors.

    medicine endocrinology step2
  • 88

    Surgical resection may be indicated for functional, symptomatic adrenal tumors despite being typically benign and nonfunctional in MEN1.

    medicine surgery step2
  • 89

    Bisphosphonate therapy is useful in patients with hyperparathyroidism who have decreased bone mineral density.

    medicine endocrinology step2
  • 90

    In hyperparathyroidism, the management may include the calcimimetic agent cinacalcet to lower serum calcium concentrations.

    medicine endocrinology step2
  • 91

    Despite the presence of adrenal tumors in MEN1, exogenous corticosteroids may be required only if adrenal insufficiency develops.

    medicine endocrinology step2
  • 92

    Patients with symptomatic hyperparathyroidism should be counseled on subtotal parathyroid resection to address high PTH secretion.

    medicine surgery step2
  • 93

    The recommended treatment for hyperparathyroidism in MEN1 is subtotal parathyroid resection.

    medicine surgery step2
  • 94

    In patients with atrial fibrillation, the most appropriate next step in management for rate control is metoprolol therapy.

    medicine cardiology step2
  • 95

    Atrial fibrillation often presents with symptoms such as palpitations, fatigue, and lightheadedness.

    medicine cardiology step2
  • 96

    In atrial fibrillation with a rapid ventricular response, the pulse is typically greater than 100 beats/minute.

    medicine cardiology step2
  • 97

    Atrial fibrillation can lead to reduced cardiac output due to decreased left ventricular filling.

    medicine cardiology step2
  • 98

    Rate control in atrial fibrillation has been shown to decrease mortality in patients with this condition.

    medicine cardiology step2
  • 99

    Chemical cardioversion is not indicated when the onset of atrial fibrillation is unknown due to the risk of embolization.

    medicine cardiology step2
  • 100

    In the treatment of atrial fibrillation with rapid ventricular response, one of the first-line agents is metoprolol.

    medicine cardiology step2
  • 101

    Atrial fibrillation typically presents with palpitations, fatigue, lightheadedness, and mild dyspnea if symptomatic.

    medicine cardiology step2
  • 102

    On ECG, atrial fibrillation shows irregularly irregular RR intervals without discernible P waves.

    medicine cardiology step2
  • 103

    In atrial fibrillation with rapid ventricular response, the diastolic filling time is reduced, leading to a reduced stroke volume.

    medicine cardiology step2
  • 104

    Rate control with metoprolol can help decrease pulse, increase left ventricular filling, and improve cardiac output in atrial fibrillation.

    medicine cardiology step2
  • 105

    Chemical cardioversion in atrial fibrillation is not recommended unless there is no risk of embolic event from atrial thrombi.

    medicine cardiology step2
  • 106

    For patients with atrial fibrillation, prefer rate control over rhythm control due to a lower risk of adverse outcomes.

    medicine cardiology step2
  • 107

    The ideal stroke volume in normal sinus rhythm is achieved when the diastolic filling time is sufficiently long.

    medicine cardiology step2
  • 108

    In the absence of anticoagulation, {c1::emergent electrical cardioversion}} is only indicated in a hemodynamically unstable patient.

    medicine cardiology step2
  • 109

    Names of specific therapies for atrial fibrillation include clopidogrel as anti-platelet therapy and low molecular-weight heparin as anticoagulation.

    medicine cardiology step2
  • 110

    In the scenario of an 82-year-old woman unable to verbalize her wishes, the most important step is to follow her advance directive which states to extubate and provide supportive care only.

    medicine ethics advance_directives step2
  • 111

    Advance directives are legal documents that allow patients to indicate their preferences for end-of-life care in advance.

    medicine ethics advance_directives step2
  • 112

    If a patient is incapacitated, medical teams must prioritize previously stated wishes in their advance directive over any emerging conflicts.

    medicine ethics advance_directives step2
  • 113

    In emergency situations, when a patient's preference is documented in an advance directive, it should dictate the clinical team's actions despite their current incapacity.

    emergency_medicine ethics advance_directives step2
  • 114

    Contacting the hospital ethics committee may be necessary when a patient's wishes conflict with their previously stated preferences, but in this case, the patient’s wishes are clear in her advance directive.

    medicine ethics advance_directives step2
  • 115

    Mechanisms like durable powers of attorney serve to uphold a patient’s wishes if they become incapacitated, similar to an advance directive.

    medicine ethics advance_directives step2
  • 116

    Advance directives are legal documents that enable patients to dictate their preferences for end-of-life care ahead of time.

    medicine advance_directives step2
  • 117

    When patients become incapacitated, physicians should refer to the patient's advance directive for care instructions.

    medicine advance_directives step2
  • 118

    Extubation is the process of removing a patient from a ventilator and providing supportive care only, following the patient's advance directive.

    medicine clinical_decision step2
  • 119

    If a patient expresses wishes that conflict with their previously stated wishes and their decisional capacity is impaired, contacting the hospital ethics committee may be indicated.

    medicine ethics step2
  • 120

    A durable power of attorney acts as a patient's health care proxy if they become incapacitated, similar to the role of advance directives.

    medicine legal step2
  • 121

    Continuing mechanical ventilation contrary to a patient's advance directive violates the ethical principle of autonomy.

    medicine ethics step2
  • 122

    Obtaining a nuclear brain blood flow scan to determine brain death is unnecessary if a patient's advance directive instructs against life prolonging measures.

    medicine diagnosis step2
  • 123

    Patients' preferences for life prolonging measures do not apply in cases of brain death, as it constitutes legal death.

    medicine legal step2
  • 124

    Advance directives are especially crucial when patients become incapacitated and cannot verbalize their wishes for care.

    medicine advance_directives step2
  • 125

    In a clinical scenario where a patient who cannot verbalize their wishes is on ventilation, the best next step is to respect their advance directive.

    medicine clinical_decision step2
  • 126

    In hereditary spherocytosis, the mutations affecting erythrocyte membrane proteins include defects in spectrin, ankyrin, band 3, and band 4.2.

    medicine hematology step2
  • 127

    The appropriate management to prevent symptoms in a patient with hereditary spherocytosis is splenectomy.

    medicine surgery step2
  • 128

    Patients with hereditary spherocytosis typically present with symptoms of hemolytic anemia, such as fatigue and jaundice.

    medicine hematology step2
  • 129

    The family history of mild anemia in this patient and her brother is suggestive of hereditary spherocytosis being inherited in an autosomal dominant pattern.

    medicine genetics step2
  • 130

    The presence of scleral icterus and a reticulocyte count of 8% indicates severe hemolysis in this clinical case of hereditary spherocytosis.

    medicine hematology step2
  • 131

    In patients with hereditary spherocytosis, the definitive treatment option is splenectomy.

    surgery hematology step2
  • 132

    Hereditary spherocytosis arises from mutations in proteins linking the erythrocyte membrane skeleton to the lipid bilayer such as spectrin, ankyrin, band 3, and band 4.2.

    medicine hematology step2
  • 133

    Patients with hereditary spherocytosis often present with splenomegaly, hemolytic anemia, and pigmented gallstones.

    medicine hematology step2
  • 134

    The typical peripheral smear in hereditary spherocytosis shows spherocytes that are dense, dark cells with loss of central pallor.

    medicine hematology step2
  • 135

    In acute hemolytic episodes of hereditary spherocytosis, reticulocytes appear as larger, pale blue erythrocytes.

    medicine hematology step2
  • 136

    Despite the use of intravenous IgG therapy and prednisone therapy, these treatments do not prevent hemolysis caused by hereditary spherocytosis.

    medicine hematology step2
  • 137

    Regimens of monthly transfusions of packed red blood cells in chronic compensated hereditary spherocytosis are not routinely required.

    medicine hematology step2
  • 138

    Bone marrow transplant, while theoretically feasible for hereditary spherocytosis, is considered high-risk and is rarely utilized due to complications like acute myelogenous leukemia.

    surgery hematology step2
  • 139

    The statement 'No preventive measures are efficacious' is incorrect since splenectomy can reduce the severity and frequency of hemolysis in hereditary spherocytosis.

    medicine hematology step2
  • 140

    The condition characterized by hemolytic anemia, increased reticulocytes, and a family history of similar symptoms is called hereditary spherocytosis.

    medicine hematology step2
  • 141

    Mutations in proteins like spectrin, ankyrin, and band 3 can lead to hereditary spherocytosis by affecting the connection between the inner membrane skeleton and outer lipid bilayer.

    medicine genetics step2
  • 142

    Hereditary spherocytosis is inherited in an autosomal dominant pattern.

    medicine genetics step2
  • 143

    Clinical symptoms of hereditary spherocytosis include jaundice, splenomegaly, and anemia.

    medicine hematology step2
  • 144

    In hereditary spherocytosis, peripheral smear shows spherocytes which are dense, dark cells with loss of central pallor.

    medicine hematology step2
  • 145

    Definitive management of hereditary spherocytosis includes performing a splenectomy.

    surgery medicine step2
  • 146

    Handing the case of hereditary spherocytosis, avoid using IV IgG therapy or prednisone therapy as they do not prevent hemolysis.

    medicine treatment step2
  • 147

    When red blood cell transfusions are indicated for hereditary spherocytosis, it is typically when hemoglobin concentration drops below 7.0 g/dL.

    medicine treatment step2
  • 148

    The absence of effective preventive measures in hereditary spherocytosis highlights the effectiveness of splenectomy in reducing hemolysis frequency.

    surgery medicine step2
  • 149

    Hereditary spherocytosis can be confirmed through a peripheral smear demonstrating spherocytes.

    medicine diagnosis step2
  • 150

    Hereditary angioedema typically presents with intermittent episodes of swelling in regions like the skin and mucosal lining of the respiratory and gastrointestinal systems.

    medicine angioedema step2
  • 151

    In hereditary angioedema, a deficiency in C1 esterase inhibitor leads to the overproduction of bradykinin, a vasodilator causing characteristic symptoms.

    medicine angioedema step2
  • 152

    The serum study most likely to be abnormal in hereditary angioedema is C1 esterase inhibitor.

    medicine diagnosis step2
  • 153

    Episodes of angioedema can be triggered by factors such as trauma, medications, or infections.

    medicine angioedema step2
  • 154

    Antihistamines are ineffective in treating episodes of hereditary angioedema, as the condition commonly self-resolves.

    medicine angioedema step2
  • 155

    A clinical feature of hereditary angioedema includes facial swelling and hoarseness due to airway involvement.

    pediatrics angioedema step2
  • 156

    Further evaluation in suspected hereditary angioedema typically shows decreased C4 complement concentration.

    medicine diagnosis step2
  • 157

    Among lab values, C1 esterase inhibitor is the most specific test indicating hereditary angioedema.

    medicine diagnosis step2
  • 158

    Hereditary angioedema is often inherited in an autosomal dominant manner.

    medicine genetics step2
  • 159

    Facial swelling episodes in hereditary angioedema may require evaluation for underlying deficiency.

    medicine angioedema step2
  • 160

    The correct choice for the most likely abnormal serum study in hereditary angioedema is B) C1 esterase inhibitor. Explanation Image

    medicine angioedema step2
  • 161

    Hereditary angioedema presents with recurrent episodes of swelling of the skin, face, lips, respiratory tract, and gastrointestinal tract. It is caused by a deficiency in C1 esterase inhibitor.

    medicine hereditary_angioedema step2
  • 162

    The overproduction of bradykinin in hereditary angioedema leads to symptoms such as swelling and is not improved by antihistamines.

    medicine hereditary_angioedema step2
  • 163

    In hereditary angioedema, a decreased concentration of C4 complement and C1 esterase inhibitor is often observed.

    medicine hereditary_angioedema step2
  • 164

    Antinuclear antibodies are typically normal in hereditary angioedema and are nonspecific autoantibodies increased in autoimmune disorders.

    medicine autoimmune_disorders step2
  • 165

    Eosinophil count is typically normal in hereditary angioedema, contrasting with allergic disorders where eosinophilia is common.

    medicine hereditary_angioedema step2
  • 166

    The vasodilatory response in hereditary angioedema is driven by increased bradykinin concentration, not by IgE-mediated pathways.

    medicine hereditary_angioedema step2
  • 167

    Episodes of angioedema can be triggered by trauma, medications, and infections.

    medicine hereditary_angioedema step2
  • 168

    Hereditary angioedema can be inherited in an autosomal dominant pattern or occur due to de novo mutations.

    medicine hereditary_angioedema step2
  • 169

    The symptoms associated with hereditary angioedema result from the overactivation of the complement system.

    medicine hereditary_angioedema step2
  • 170

    The educational objective regarding hereditary angioedema highlights its characteristic symptom: recurrent swelling.

    medicine hereditary_angioedema step2
  • 171

    Hereditary angioedema manifests most notably through episodes of swelling in the respiratory tract and gastrointestinal tract.

    medicine hereditary_angioedema step2
  • 172

    The initial presentation of a patient with a suspected perforated peptic ulcer includes symptoms like vomiting, severe abdominal pain, and fever.

    medicine surgery step2
  • 173

    In the context of a perforated peptic ulcer, the most appropriate next step in diagnosis is performing X-rays of the chest and abdomen.

    medicine surgery step2
  • 174

    A perforated peptic ulcer can lead to intra-abdominal free air and peritoneal irritation, requiring immediate surgical intervention.

    medicine surgery step2
  • 175

    Signs of peritonitis in a patient may include abdominal rigidity, tenderness, and absent bowel sounds.

    medicine surgery step2
  • 176

    Patients with suspected perforated peptic ulcers should be treated with broad-spectrum antibiotics and surgery to repair the perforation.

    medicine surgery step2
  • 177

    Barium enema and colonoscopy are not useful for diagnosing a perforated peptic ulcer as they examine abnormalities in the large intestine.

    medicine surgery step2
  • 178

    The presence of fever, abdominal pain, and a history of intermittent epigastric pain suggests the possibility of a perforated ulcer.

    medicine surgery step2
  • 179

    Diagnosing a perforated viscus requires imaging to confirm free air under the diaphragm, typically achieved with upright X-rays.

    medicine surgery step2
  • 180

    A patient with fever, abdominal pain, and history of intermittent epigastric pain raises suspicion for a perforated peptic ulcer.

    surgery clinical_decision step2
  • 181

    In a case of suspected perforated peptic ulcer, which diagnostic imaging is often used to confirm the diagnosis? Upright x-rays of the chest and abdomen can show free air under the diaphragm.

    surgery imaging step2
  • 182

    A perforated peptic ulcer is classified as a surgical emergency requiring immediate treatment with broad-spectrum antibiotics and surgery.

    surgery clinical_decision step2
  • 183

    When diagnosing perforated peptic ulcer, water-soluble contrast swallow is contraindicated in patients who are vomiting due to the risk of pneumonitis.

    surgery clinical_decision step2
  • 184

    Following a perforation of a peptic ulcer, esophagogastroduodenoscopy is contraindicated in patients due to the associated risks.

    surgery clinical_decision step2
  • 185

    In cases of perforated peptic ulcer, which imaging modality is sensitive and specific for surgical planning but takes longer than x-rays? CT scan of the abdomen.

    surgery imaging step2
  • 186

    The primary management strategy for perforated peptic ulcer includes surgery and lavage of the peritoneal cavity.

    surgery management step2
  • 187

    An educational objective related to perforated peptic ulcer is that rapid diagnosis is necessary to expedite management of these patients.

    surgery education step2
  • 188

    The condition characterized by pain, swelling, and redness around the eye, often resulting from a local infection, is known as orbital cellulitis.

    pediatrics emergency_medicine step2
  • 189

    Complications of orbital cellulitis include cavernous sinus thrombosis and potential irreversible damage to the optic nerve.

    pediatrics emergency_medicine step2
  • 190

    Systemic symptoms like fever and headache in a child presenting with eye swelling suggest the need to evaluate for orbital cellulitis.

    pediatrics emergency_medicine step2
  • 191

    In cases of orbital cellulitis, the most common pathogens are Gram-positive organisms such as S. aureus and S. pneumoniae.

    pediatrics emergency_medicine step2
  • 192

    A CT scan may be utilized to confirm the diagnosis of orbital cellulitis and evaluate for potential complications.

    pediatrics emergency_medicine step2
  • 193

    Orbital cellulitis typically results from local spread of bacteria from an adjacent infection, particularly of the paranasal sinuses.

    pediatrics emergency_medicine step2
  • 194

    Orbital cellulitis is a medical emergency because it may cause irreversible damage to the optic nerve and carry greater risk for spread to the cavernous sinus.

    emergency_medicine neuroscience step2
  • 195

    Common organisms causing Orbital cellulitis include S. aureus and S. pneumoniae.

    medicine infectious_diseases step2
  • 196

    Patients with Orbital cellulitis may present with fever, pain, and erythema, swelling, and warmth of the orbit.

    pediatrics step2
  • 197

    An emergent CT scan is required for patients suspected of having Orbital cellulitis to confirm the presence of an infection.

    surgery step2
  • 198

    The typical clinical presentation of Orbital cellulitis includes proptosis and reduced mobility of the eye.

    pediatrics step2
  • 199

    Optic nerve dysfunction in Orbital cellulitis may be indicated by reduced color perception or optic disc edema.

    neurology step2
  • 200

    Orbital cellulitis can result from local spread of bacteria from adjacent infections of the paranasal sinuses or upper respiratory tract.

    infectious_diseases medicine step2
  • 201

    Immediate treatment for Orbital cellulitis involves broad-spectrum intravenous antibiotics.

    medicine step2
  • 202

    Differentiating Orbital cellulitis from preseptal cellulitis is important as the latter does not cause proptosis.

    emergency_medicine step2
  • 203

    In cases of Orbital cellulitis, the presence of a subperiosteal abscess can be evaluated through a CT scan.

    surgery step2
  • 204

    Besides bacterial infection, Orbital cellulitis can result from orbital trauma or ocular surgery.

    surgery step2
  • 205

    Orbital cellulitis typically results from local spread of bacteria from an adjacent infection, such as the paranasal sinuses or upper respiratory tract.

    medicine orbital_cellulitis step2
  • 206

    In patients with orbital cellulitis, key symptoms include fever, pain, and erythema of the orbit.

    medicine orbital_cellulitis step2
  • 207

    Patients suspected of having orbital cellulitis should undergo an emergent CT scan to confirm the presence of an orbital infection.

    medicine orbital_cellulitis step2
  • 208

    Immediate treatment for orbital cellulitis should include broad-spectrum intravenous antibiotics.

    medicine orbital_cellulitis step2
  • 209

    Symptoms of orbital cellulitis may include proptosis and pain with extraocular movements.

    medicine orbital_cellulitis step2
  • 210

    The presence of a subperiosteal abscess can be confirmed via CT scan in cases of orbital cellulitis.

    medicine orbital_cellulitis step2
  • 211

    Acute angle closure glaucoma does NOT present with fever and does NOT cause proptosis.

    medicine glaucoma step2
  • 212

    Neuroblastoma may present with proptosis in the setting of orbital metastasis, but fever and acute onset symptoms suggest orbital cellulitis.

    medicine neuroblastoma step2
  • 213

    Preseptal cellulitis does not cause proptosis or pain with extraocular movements.

    medicine preseptal_cellulitis step2
  • 214

    In patients with peripheral edema, avoid using dihydropyridine calcium-channel blockers like nifedipine, which can exacerbate swelling.

    medicine pharmacology step2
  • 215

    Nifedipine, a dihydropyridine calcium-channel blocker, acts primarily on vascular smooth muscle and can cause increased peripheral edema.

    medicine pharmacology step2
  • 216

    Atenolol does NOT typically cause peripheral edema, making it a safer choice compared to dihydropyridine CCBs.

    medicine pharmacology step2
  • 217

    Clonidine is an a₂-adrenergic agonist that leads to decreased sympathetic outflow, relaxation of vascular tone, and potential side effects like bradycardia.

    medicine pharmacology step2
  • 218

    For hypertensive patients, if peripheral edema is a concern, avoid nifedipine and similar medications that can worsen this condition.

    medicine pharmacology step2
  • 219

    Patients treated with dihydropyridine CCBs may experience adverse effects including headache, facial flushing, and gingival hyperplasia.

    medicine pharmacology step2
  • 220

    The main action of dihydropyridine calcium-channel blockers, such as nifedipine or amlodipine, is that they are potent arteriolar vasodilators that reduce blood pressure by decreasing vascular peripheral resistance.

    medicine pharmacology step2
  • 221

    Calcium-channel blockers inhibit L-type calcium channels on smooth muscle cells and cardiomyocytes, leading to vasodilation and decreased cardiomyocyte contractility.

    medicine physiology step2
  • 222

    Dihydropyridine calcium-channel blockers primarily act on vascular smooth muscle cells and have minimal direct activity on cardiomyocytes.

    medicine pharmacology step2
  • 223

    Common side effects of calcium-channel blockers may include peripheral edema, which is one of the most common reasons for treatment discontinuation.

    medicine pharmacology step2
  • 224

    Adverse effects of dihydropyridine calcium-channel blockers may also include headache, lightheadedness, facial flushing, and gingival hyperplasia.

    medicine pharmacology step2
  • 225

    ACE-inhibitors, like lisinopril, are used for the management of heart failure but typically do not cause peripheral edema.

    medicine cardiology step2
  • 226

    Angiotensin II receptor blockers, such as losartan, may lead to hypotension and hyperkalemia but do not typically cause peripheral edema.

    medicine cardiology step2
  • 227

    Atenolol, a cardioselective β-adrenergic blocker, may exacerbate symptoms of heart failure in patients with aortic stenosis but does not cause peripheral edema.

    medicine cardiology step2
  • 228

    Clonidine, an α2-adrenergic agonist, can cause side effects like orthostatic hypotension and rebound hypertension when discontinued.

    medicine pharmacology step2
  • 229

    In the case of a 37-year-old woman who smokes more than 15 cigarettes daily and is over 35 years old, it is recommended to discontinue the oral contraceptive due to an increased risk of stroke.

    obgyn step2 clinical_decision
  • 230

    For women using oral contraceptives, a smoking history of more than 15 cigarettes daily is a significant risk factor for thrombosis and stroke.

    obgyn step2 clinical_decision
  • 231

    The risk of stroke with oral contraceptive use significantly increases in women who are over 35 years old and smoke heavily.

    obgyn step2 clinical_decision
  • 232

    The Centers for Disease Control advises against prescribing oral contraceptives to women with a history of smoking and uncontrolled hypertension.

    obgyn step2 clinical_decision
  • 233

    Alternative contraceptive methods for women at increased risk should include options like a copper IUD.

    obgyn step2 clinical_decision
  • 234

    The use of oral contraceptives is associated with significant adverse effects, including an increased risk for venous thromboembolism, myocardial infarction, and stroke.

    medicine obgyn step2
  • 235

    Patients over 35 years of age who smoke more than 15 cigarettes daily have a significantly increased risk for stroke when using oral contraceptives.

    medicine obgyn step2
  • 236

    It is recommended that patients aged greater than 35 years and smoking more than 15 cigarettes daily should discontinue their oral contraceptive use to reduce stroke risk.

    medicine obgyn step2
  • 237

    An alternative contraceptive option for patients with contraindications to oral contraceptives is a copper IUD.

    medicine obgyn step2
  • 238

    Daily aspirin is not recommended for patients without a history of stroke due to lack of proven benefit and increased risk for bleeding.

    medicine obgyn step2
  • 239

    Despite hypertension, stopping an oral contraceptive has a greater impact on stroke risk compared to initiating antihypertensive therapy.

    medicine obgyn step2
  • 240

    The CDC and WHO provide recommendations for absolute contraindications for oral contraceptives, including uncontrolled hypertension and certain medical conditions like migraine with aura.

    medicine obgyn step2
  • 241

    Patients using oral contraceptives should be informed about risks like myocardial infarction and stroke, especially if they have a history of venous thromboembolism.

    medicine obgyn step2
  • 242

    The most likely diagnosis for a patient experiencing progressive loss of urine and a postvoid residual volume of 500 mL is overflow incontinence.

    medicine urology step2
  • 243

    Overflow incontinence occurs when bladder emptying is impaired due to insufficient pressure overcoming sphincter closing pressures, resulting in leakage during Valsalva or increased abdominal pressure.

    medicine urology step2
  • 244

    Treatment for overflow incontinence includes bethanechol, a muscarinic agent, or intermittent catheterization.

    medicine urology step2
  • 245

    In contrast to overflow incontinence, an overactive bladder (choice A) is treated with oxybutynin, an antimuscarinic medication.

    medicine urology step2
  • 246

    In overflow incontinence, patients commonly exhibit urinary retention with an inability to void, alongside increased postvoid residual volume, as seen in urodynamic studies.

    medicine urology step2
  • 247

    Patients with conditions like diabetic neuropathy may develop overflow incontinence due to bladder atony.

    medicine urology step2
  • 248

    Key factors for diagnosing overflow incontinence involve identifying the patient's urinary retention and variable causes such as benign prostatic hyperplasia.

    medicine urology step2
  • 249

    The image provides a representation of symptoms and treatments related to overflow incontinence. Overflow Incontinence Image

    medicine urology step2
  • 250

    The condition characterized by impaired bladder emptying leading to urinary leakage is known as overflow incontinence.

    urology medicine step2
  • 251

    Common causes of overflow incontinence include neurologic insults and bladder outlet obstruction.

    urology medicine step2
  • 252

    Urodynamic studies are used to diagnose overflow incontinence by revealing an increased postvoid residual volume.

    urology diagnostics step2
  • 253

    Treatment for overflow incontinence may include bethanechol to promote bladder contraction or intermittent catheterization.

    urology medication step2
  • 254

    In contrast to overflow incontinence, an overactive bladder is treated with oxybutynin.

    urology medication step2
  • 255

    Patients with stress incontinence experience urine leakage triggered by an increase in abdominal pressure, such as during sneezing.

    urology medicine step2
  • 256

    A typical presentation for urinary tract infections includes frequency, urgency, and dysuria, alongside suprapubic pain.

    urology medicine step2
  • 257

    A condition resulting from gynecologic surgery that leads to urine leakage from bladder to vagina is known as vesicovaginal fistula.

    urology medicine step2
  • 258

    The educational objective is that overflow incontinence occurs when damaged bladder emptying leads to leakages caused by intravesical hydrostatic pressure.

    urology medicine step2
  • 259

    The patient is diagnosed with chronic obstructive pulmonary disease (COPD) due to symptoms such as progressive shortness of breath and chronic cough. What is the most appropriate next step in management? A) CT scan of the chest B) Prednisone therapy C) Theophylline therapy D) Oxygen therapy E) Use of an ipratropium inhaler.

    medicine copd step2
  • 260

    COPD is characterized by airflow obstruction on expiration due to a combination of chronic bronchitis and/or emphysema.

    medicine copd step2
  • 261

    In COPD, physical examination may show decreased breath sounds and prolonged expiratory phase. Heart sounds may be distant due to emphysema.

    medicine copd step2
  • 262

    The severity of obstructive lung disease is assessed using the FEV1/FVC ratio and FEV1 reduction compared to predicted values.

    medicine pulmonary step2
  • 263

    For managing COPD, the focus is on smoking cessation and supplemental oxygen to reduce mortality.

    medicine copd step2
  • 264

    Inhaled medications for COPD management include short-acting β-adrenergic agonists, long-acting β-adrenergic agonists, and muscarinic antagonists like ipratropium.

    medicine copd step2
  • 265

    The optimal treatment for COPD symptoms includes using an ipratropium inhaler along with other inhaled medications.

    medicine copd step2
  • 266

    Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction on expiration due to a combination of chronic bronchitis and/or emphysema.

    medicine copd step2
  • 267

    In COPD, the physical examination may reveal decreased breath sounds and a prolonged expiratory phase due to positive intrathoracic pressure.

    medicine copd step2
  • 268

    The most useful test for diagnosing obstructive lung disease is spirometry, which assesses the FEV1/FVC ratio.

    medicine diagnostics step2
  • 269

    Management of COPD includes smoking cessation and supplemental oxygen to reduce mortality and improve quality of life.

    medicine copd step2
  • 270

    For managing symptoms of COPD, inhaled short-acting β-adrenergic agonists, long-acting β-adrenergic agonists, and muscarinic antagonists (like ipratropium) are used.

    medicine copd step2
  • 271

    Long-term supplemental oxygen therapy is indicated for chronic hypoxemia, specifically when arterial oxygen tension is less than or equal to 55 mm Hg or peripheral oxygen saturation is less than or equal to 88%.

    medicine copd step2
  • 272

    When managing COPD, the use of an ipratropium inhaler is a key recommendation.

    medicine copd step2
  • 273

    Prednisone is generally used for acute exacerbations of COPD rather than for chronic stable symptom management; inhaled corticosteroids are preferred for the latter despite prednisone's role in inflammation reduction.

    medicine copd step2
  • 274

    The effectiveness of Theophylline therapy for COPD has declined, leading to its decreased use due to adverse effects compared to currently recommended therapies.

    medicine copd step2
  • 275

    COPD is an obstructive lung disease associated with tobacco use characterized by airflow obstruction. COPD

    medicine copd step2
  • 276

    One of the critical evaluations for pulmonary abnormalities is spirometry. It is the most useful in diagnosing obstructive lung disease. COPD

    medicine pulmonary step2
  • 277

    In COPD diagnosis, a decrease in the ratio of FEV1 to FVC indicates obstructive lung disease. COPD

    medicine pulmonary step2
  • 278

    The mainstay of COPD treatment includes smoking cessation and supplemental oxygen to reduce mortality. COPD

    medicine treatment step2
  • 279

    Management of COPD symptoms can include inhaled short-acting ß-adrenergic agonists, long-acting ß-adrenergic agonists, and muscarinic antagonists like ipratropium. COPD

    medicine pharmacology step2
  • 280

    The most appropriate inhaler to initiate for COPD management is ipratropium. COPD

    medicine pharmacology step2
  • 281

    Oxygen therapy in COPD is indicated for chronic hypoxemia, defined as an arterial oxygen tension less than or equal to 55 mm Hg or a peripheral oxygen saturation less than or equal to 88%. COPD

    medicine treatment step2
  • 282

    A previously healthy 2-year-old girl presents with a 2-minute episode of generalized shaking and unresponsiveness. Her temperature is 39.8°C. What is the most appropriate next step in management for her febrile seizure?

    pediatrics neurology step2
  • 283

    Febrile seizures typically occur in children between 6 months and 5 years. They can be classified as simple or complex. Simple febrile seizures are generalized and last for less than 15 minutes.

    pediatrics neurology step2
  • 284

    Management of a simple febrile seizure includes antibiotics for acute otitis media and antipyretics, as no antiepileptic treatment is required.

    pediatrics neurology step2
  • 285

    In a case of a febrile seizure, a CT scan of the head is appropriate when there are abnormal neurologic findings or focal signs present on examination.

    pediatrics neurology step2
  • 286

    Despite a febrile seizure incident, the majority are simple and do not carry a significantly increased risk for future epilepsy.

    pediatrics neurology step2
  • 287

    The anchor for management in cases of febrile seizures is acute otitis media. What initial treatment should be considered?

    pediatrics neurology step2
  • 288

    Generalized tonic-clonic seizures in the context of fever suggest a diagnosis of simple febrile seizure. Management should focus on supportive care rather than antiepileptic drugs.

    pediatrics neurology step2
  • 289

    For a child experiencing a simple febrile seizure, the most prudent next step is oral antibiotic therapy as a management approach.

    pediatrics neurology step2
  • 290

    In children between the ages of 6 months and 5 years, simple febrile seizures are characterized by being generalized and lasting for less than 15 minutes.

    pediatrics step2
  • 291

    The majority of febrile seizures are classified as simple, which typically do not require treatment or invasive testing.

    pediatrics step2
  • 292

    Management of simple febrile seizures includes treating the underlying condition, such as prescribing antibiotics for acute otitis media.

    pediatrics step2
  • 293

    A key distinguishing feature of febrile seizures is that they are often triggered by a febrile illness, in contrast to other seizure types caused by more serious conditions.

    pediatrics step2
  • 294

    CT scans of the head are indicated for febrile seizures if a child presents with abnormal neurologic examination or focal findings.

    pediatrics step2
  • 295

    Lumbar puncture is indicated in cases where there is suspicion of meningitis in a child presenting with fever and altered mental status.

    pediatrics step2
  • 296

    Despite associated infections, simple febrile seizures do not require treatment with antiepileptic medications.

    pediatrics step2
  • 297

    Simple febrile seizures typically do not carry a significantly increased risk for future epilepsy.

    pediatrics step2
  • 298

    Educational Objective: Simple febrile seizures do not require treatment or invasive testing.

    pediatrics step2
  • 299

    Management of simple febrile seizures involves providing antipyretics to reduce fever.

    pediatrics step2
  • 300

    In the case of alcohol withdrawal, symptoms such as tremors, anxiety, restlessness, headache, nausea, and diaphoresis typically occur hours after the cessation of alcohol use.

    psychiatry step2 alcohol_withdrawal
  • 301

    Delirium tremens, a severe complication of alcohol withdrawal, includes symptoms such as severe confusion, agitation, and autonomic instability.

    psychiatry step2 alcohol_withdrawal
  • 302

    Management of alcohol withdrawal typically requires benzodiazepines to address agitation and prevent further withdrawal symptoms.

    psychiatry step2 alcohol_withdrawal
  • 303

    The central mechanism by which alcohol acts is by increasing nervous system activity of GABA, the primary inhibitory neurotransmitter.

    psychiatry step2 alcohol_withdrawal
  • 304

    Signs of alcohol intoxication can include slurred speech, ataxia, and altered mental status.

    psychiatry step2 alcohol_intoxication
  • 305

    In a patient with alcohol withdrawal, it is crucial to provide nutritional supplementation to support recovery and prevent complications.

    psychiatry step2 alcohol_withdrawal
  • 306

    Alcohol withdrawal symptoms can include diaphoretic behavior and mild tremors.

    psychiatry step2 alcohol_withdrawal
  • 307

    Alcoholic hallucinosis refers to auditory or visual hallucinations without confusion during alcohol withdrawal.

    psychiatry step2 alcohol_withdrawal
  • 308

    For a patient undergoing alcohol withdrawal, regular vital sign checks are essential for monitoring autonomic stability.

    psychiatry step2 alcohol_withdrawal
  • 309

    Alcohol withdrawal commonly presents with symptoms such as: - tremors - anxiety - restlessness - headache - nausea - diaphoresis - autonomic instability with tachycardia and hypertension.

    psychiatry step2
  • 310

    The most concerning and life-threatening complication of alcohol withdrawal is delirium tremens, which involves severe confusion and disorientation.

    psychiatry step2
  • 311

    Management of alcohol withdrawal includes supportive care with benzodiazepines to address agitation and prevent withdrawal symptoms.

    psychiatry step2
  • 312

    Other complications of alcohol withdrawal include alcoholic hallucinosis and seizures.

    psychiatry step2
  • 313

    Abrupt discontinuation of alcohol leads to sympathetic overdrive and can result in withdrawal symptoms appearing hours after cessation.

    psychiatry step2
  • 314

    Opioid withdrawal symptoms can include symptoms such as: - restlessness - tachycardia - hypertension - tremors - nausea - vomiting.

    psychiatry step2
  • 315

    In alcohol withdrawal, autonomic instability may present with fluctuations in pulse, blood pressure, and temperature, often associated with symptoms like diaphoresis.

    psychiatry step2
  • 316

    Compared to alcohol withdrawal, opioid withdrawal typically also presents with lacrimation, rhinorrhea, and piloerection.

    psychiatry step2
  • 317

    In a patient with poorly controlled type 1 diabetes mellitus, which condition can be diagnosed by measuring urine microalbumin concentration?

    diabetes nephrology step2
  • 318

    The pathophysiology of diabetic nephropathy involves nonenzymatic glycosylation of the glomerular basement membrane, resulting in thickening of the basement membrane and increased permeability to solutes.

    diabetes nephrology pathophysiology step2
  • 319

    Characteristically, diabetic nephropathy presents with eosinophilic nodular glomerulosclerosis known as Kimmelstiel-Wilson lesions on light microscopy.

    diabetes nephrology histology step2
  • 320

    Initially, diabetic nephropathy begins as microalbuminuria, progressing to macroalbuminuria and eventually to end-stage renal disease.

    diabetes nephrology kidney step2
  • 321

    The best next step for a patient with non-compliance and a hemoglobin A₁c > 10% in the context of diabetes management is measurement of urine microalbumin concentration.

    diabetes management step2
  • 322

    Measurement of urine microalbumin concentration can help with the diagnosis of early diabetic nephropathy and direct management of diabetes mellitus.

    medicine diabetes step2
  • 323

    Long-standing hyperglycemia can lead to complications such as diabetic nephropathy.

    medicine diabetes step2
  • 324

    The pathophysiology of diabetic nephropathy involves nonenzymatic glycosylation of the glomerular basement membrane and efferent arterioles.

    medicine diabetes step2
  • 325

    Diabetic nephropathy characteristically presents with eosinophilic nodular glomerulosclerosis on light microscopy, also known as Kimmelstiel-Wilson lesions.

    medicine diabetes step2
  • 326

    Diabetic nephropathy initially begins as microalbuminuria, progressing to macroalbuminuria, and eventually to end-stage renal disease.

    medicine diabetes step2
  • 327

    Mesangial expansion of the efferent arteriole can lead to an increase in glomerular filtration rate (GFR).

    medicine diabetes step2
学习笔记

Tuberous Sclerosis Complex (TSC)

Tuberous Sclerosis Complex (TSC)

Tuberous sclerosis complex (TSC) is an autosomal dominant neurocutaneous disorder characterized by benign tumors known as hamartomas. It often affects multiple organ systems, particularly the skin and central nervous system (CNS).

Key Features

  • Genetic Basis: Caused by mutations in either the TSC1 or TSC2 genes.
  • Skin Manifestations: Includes hypopigmented macules ("confetti" macules), ash leaf spots, angiofibromas, shagreen patches, and fibrous plaques on the forehead.
  • CNS Involvement: Often presents with glioneuronal hamartomas (cortical tubers), subependymal nodules, and giant cell tumors.
  • Common Presentations: First symptoms often include seizures and cognitive dysfunction, affecting approximately 66% of patients.
  • Other Tumors: Cardiovascular tumors (like cardiac rhabdomyomas) and renal tumors (angiomyolipomas) may also occur.

Diagnosis

  • MRI Findings: Characteristic CNS lesions, particularly cortical tubers.

Treatment

Management may include addressing seizures and monitoring for potential manifestations in various organ systems.

Cohort Study

Cohort Study

Cohort studies are observational studies that follow a group of individuals over time to assess the impact of exposures or interventions on health outcomes.

Characteristics

  • Prospective Design: Hypotheses are formulated before participant enrollment.
  • Outcome Measurement: Compares the incidence of outcomes between exposed and unexposed groups, allowing for the calculation of relative risks (RR).

Educational Objective

  • Understanding the long-term effects of exposures on health.

Ovarian Cancer Management

Ovarian Cancer Management

In postmenopausal women with a palpable ovary and elevated CA-125, the likelihood of ovarian malignancy is concerning.

Management Steps

  1. Surgical Intervention: Followed by chemotherapy, especially if malignancy is confirmed.
  2. Patient Monitoring: Essential for assessing tumor response to treatment and managing side effects.

Atrial Fibrillation Management

Atrial Fibrillation Management

In patients with rapid ventricular responses from atrial fibrillation, metoprolol is a first-line agent for rate control.

Treatment Goals

  • Reduce heart rate.
  • Improve hemodynamic status.
  • Regulate diastolic filling and cardiac output.

Urgent Decisions with Advance Directives

Advance Directives

Advance directives allow patients to specify their preferences for medical treatment in scenarios where they cannot communicate their wishes.

Importance

  • Autonomy in end-of-life care.
  • Legal enforceability in emergency situations.

Hereditary Spherocytosis

Hereditary Spherocytosis

A genetic disorder characterized by mutations affecting erythrocyte membrane proteins, leading to hemolytic anemia.

Treatment

  • Splenectomy is the definitive management.
  • Recognition of the condition is critical to prevent unnecessary treatments.

Management of Angioedema

Management of Angioedema

Hereditary angioedema results from C1 esterase inhibitor deficiency, causing recurrent swelling episodes.

Diagnosis

  • Check C1 esterase levels.
  • Absence of response to antihistamines.

Treatment

  • Administration of C1 inhibitor concentrate or attenuated androgen therapy.

Management of Peptic Ulcer Perforation

Management of Peptic Ulcer Perforation

Perforated peptic ulcers present as surgical emergencies, requiring rapid diagnosis through imaging.

Diagnostic Steps

  1. X-ray or CT Scanning: Quick identification of free air under the diaphragm.

Treatment

  • Immediate surgery and antibiotic therapy.

Orbital Cellulitis Considerations

Orbital Cellulitis

A serious condition involving infection behind the orbital septum, often arising from sinus infections.

Clinical Signs

  • Proptosis, pain with movement, and potential vision loss.

Management

  • Immediate computed tomography (CT) to evaluate for abscess formation and begin intravenous antibiotics.

Antihypertensive Medications

Antihypertensive Medications

Dihydropyridine calcium-channel blockers, such as nifedipine, can exacerbate peripheral edema due to their vasodilatory effects.

Managing Peripheral Edema

  • Consider alternatives if peripheral edema is significant or tolerable.

Oral Contraceptives and Stroke Risk

Oral Contraceptives and Stroke Risk

Women over 35 who smoke should discontinue oral contraceptives to mitigate risks of thromboembolic events.

Management Recommendations

  • Discuss alternative contraceptive methods.

Overflow Incontinence

Overflow Incontinence

Overflow incontinence occurs when bladder emptying is impaired, leading to excess volume and leakage due to high abdominal pressure.

Management

  • Address underlying causes, consider catheterization, or use medications to enhance bladder contraction.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

COPD is characterized by airflow limitation due to chronic bronchitis and/or emphysema.

Treatment Strategies

  • Smoking cessation, inhalers (short and long-acting), and oxygen therapy for hypoxemia.
  • Routine monitoring of pulmonary function.

Febrile Seizures

Febrile Seizures

Febrile seizures are common in children aged 6 months - 5 years and typically do not require aggressive intervention.

Management

  • Provide supportive care and address underlying infection.

Alcohol Withdrawal

Alcohol Withdrawal

Occurs following abrupt cessation of alcohol intake; symptoms may include tremors, anxiety, and autonomic instability.

Management

  • Use benzodiazepines for symptom control and supportive care.

Diabetes Management and Microalbuminuria

Monitoring for Diabetic Nephropathy

In poorly controlled diabetes, monitoring urine microalbumin levels helps assess renal function and risk for complications.

Strategies

  • Regular screening and management of blood glucose levels.